Illumina, Inc. and Solexa, Inc. have announced that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger ...

Genome sequencing company Illumina Inc ILMN has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006 was one of the most important in ...

Solexa (www.solexa.com) claims that its new technology will transform sequencing by reducing cost and increasing throughput. “Our technology will offer a hundred-fold improvement in productivity and a ...

Something is new in human DNA sequencing: a technology that could speed up the process by 100 times and that slashes the costs way below those of the current state-of-the-art system. Solexa (SLXA) ...

Shares in Hayward biotech company Solexa Inc. jumped almost 30 percent after it announced a $600 million stock-for-stock merger agreement Monday with Illumina Inc. of San Diego, another maker of ...

HAYWARD, Calif. (September 6, 2005) – Solexa, Inc. (Nasdaq: SLXA) today announced that its researchers in collaboration with the Delaware Biotechnology Institute and the University of Delaware ...

NEW YORK (Reuters) - Gene-testing technology company Illumina Inc. will acquire Solexa Inc. in a stock deal valuing the developer of genetic analysis systems at about $600 million, the companies said ...

Nick McCooke, CEO of Solexa, has a bold goal: to analyze, in one day, the whole genome of an individual for one thousand dollars. The Cambridge, UK-based company (www.solexa.com) is developing ...